Gene expression profiling in biopsied tumor tissues

Details Gene expression profiling in biopsied tumor tissues Gene expression profiling in biopsied tumor tissues

2006-06-09

2010-12-28

Kapushoc, Stephen (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S024300, C536S023100, C435S091200

Reexamination Certificate

active

07858304

ABSTRACT:
The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. The invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.

REFERENCES:
patent: 4699877 (1987-10-01), Cline et al.
patent: 5015568 (1991-05-01), Tsujimoto et al.
patent: 5459251 (1995-10-01), Tsujimoto et al.
patent: 5563035 (1996-10-01), Weigel
patent: RE35491 (1997-04-01), Cline et al.
patent: 5858678 (1999-01-01), Chinnadurai
patent: 5952179 (1999-09-01), Chinnadurai
patent: 5985553 (1999-11-01), King et al.
patent: 6180333 (2001-01-01), Giordano
patent: 6207452 (2001-03-01), Govindaswamy
patent: 6271002 (2001-08-01), Linsley et al.
patent: 6316208 (2001-11-01), Roberts et al.
patent: 6322986 (2001-11-01), Ross
patent: 6331396 (2001-12-01), Silverman et al.
patent: 6414134 (2002-07-01), Reed
patent: 6582919 (2003-06-01), Danenberg
patent: 6602670 (2003-08-01), Danenberg
patent: 6618679 (2003-09-01), Loehrlein et al.
patent: 7081340 (2006-07-01), Baker et al.
patent: 2002/0009736 (2002-01-01), Wang
patent: 2003/0073112 (2003-04-01), Zhang et al.
patent: 2003/0104499 (2003-06-01), Pressman et al.
patent: 2003/0165952 (2003-09-01), Linnarsson et al.
patent: 2003/0180791 (2003-09-01), Chinnadurai
patent: 2003/0198970 (2003-10-01), Roberts
patent: 2003/0225528 (2003-12-01), Baker et al.
patent: 2004/0009489 (2004-01-01), Golub et al.
patent: 2004/0133352 (2004-07-01), Bevilacqua et al.
patent: 2004/0209290 (2004-10-01), Cobleigh et al.
patent: 2006/0286565 (2006-12-01), Baker et al.
patent: 2007/0059737 (2007-03-01), Baker et al.
patent: 2007/0065845 (2007-03-01), Baker et al.
patent: 2007/0141587 (2007-06-01), Baker et al.
patent: 2007/0141588 (2007-06-01), Baker et al.
patent: 2007/0141589 (2007-06-01), Baker et al.
patent: 0 108 564 (1988-05-01), None
patent: 1 365 034 (2003-11-01), None
patent: WO 98/33450 (1998-08-01), None
patent: WO 99/02714 (1999-01-01), None
patent: WO 00/50595 (2000-08-01), None
patent: WO 00/55173 (2000-09-01), None
patent: WO 00/55629 (2000-09-01), None
patent: WO 00/60076 (2000-10-01), None
patent: WO 01/04343 (2001-01-01), None
patent: WO 01/25250 (2001-04-01), None
patent: WO 01/40466 (2001-06-01), None
patent: WO 01/40517 (2001-06-01), None
patent: WO 01/55320 (2001-08-01), None
patent: WO 01/70979 (2001-09-01), None
patent: WO 02/00677 (2002-01-01), None
patent: WO 02/06526 (2002-01-01), None
patent: WO 02/08260 (2002-01-01), None
patent: WO 02/08261 (2002-01-01), None
patent: WO 02/08282 (2002-01-01), None
patent: WO 02/08765 (2002-01-01), None
patent: WO 02/10436 (2002-02-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO 02/017852 (2002-07-01), None
patent: WO 02/055988 (2002-07-01), None
patent: WO 02/059271 (2002-08-01), None
patent: WO 02/059377 (2002-08-01), None
patent: WO 02/068579 (2002-09-01), None
patent: WO 02/103320 (2002-12-01), None
patent: WO 03/011897 (2003-02-01), None
patent: WO 03/083096 (2003-10-01), None
Lucentini, Jack. Gene Association Studies Typically Wrong. 2004. The Scientist vol. 18, pp. 1-4.
Wu, Thomas. Analyzing gene expression data from DNA microarrays to identify candidate genes. 2001. Journal of Pathology. vol. 195 pp. 53-65.
Miyoshi, Yasuo et al. Association of centrosmal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. 2001. International Jouranl of Cancer. vol. 92 pp. 370-373.
The array finder at www.affymetrix.com accessed Jul. 3, 2008 demonstrates that probes for the ESR1 gene are on the HU95A array.
Unger, Meredith et al. Characterization of adjacent breast tumors using oligonucleotide microarrays. 2001. Breast Cancer Research vol. 3 ages 336-341.
Gruvberger Sofia et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. 2001. Breast Cancer Research. vol. 61 pp. 5979-5984.
Specht, Katja et al. Quantitative gene expression analysis in microdissected archival formalin fixed and paraffin embedded tumor tissue. 2001 American Journal of Pathology. vol. 158 pp. 419-429.
Sorlie, Therese. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. 2001 PNAS vol. 98 pp. 10869-10874.
The array finder at www.affymetrix.com accessed Jul. 3, 2008 demonstrates that probes for the STK15 gene are on the HU95A array.
Chan, Eric. Integrating Transcriptomics and Proteomics. 2006. Genomics and Proteomics, available online from www.genpromag.com, pp. 1-6.
Schmittgen, Thomas, et al. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. 2003 International Jouranl of Cancer. vol. 107 pp. 323-329.
Lee, Andrew, et al. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endotherlial growth factor expression and angiogenesis. 1998 Journal of Pathology vol. 185 pp. 394-401.
Brabender, Jan, et al.;Epidermal Growth Factor Receptor and HER2-neu mRNA Expression in Non-Small Cell Lung Cancer Is Correlated with Survival, Clinical Cancer Research; vol. 7, Jul. 2001; pp. 1850-1855.
Ding, Chunming, et al.;A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS, PNAS, vol. 100:6; Mar. 18, 2003; pp. 3059-3064.
Cambridge Healthtech Institute Conference Agenda; “Enabling Molecular Profiling With Cellular Resolution: Microgenomics Using Homogeneous Cell Samples”; Dec. 2002; 5 pgs.
Yang, Li, et al.;BADGE,BeadsArray for theDetection ofGeneExpression, a High-Throughput Diagnostic Bioassay; Genome Research; vol. 11; 2001; pp. 1888-1898.
Affymetrix Inc.: “Affymetrix GeneChip Human Genome U95 Version 2 Set HG-U95A,”GEO, XX, XX, 1-243 (2002).
Bhattacharjee et al., “Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses”, Proceedings of the National Academy of Sciences of USA, vol. 98, No. 24, pp. 13790-13795 (2001).
Chang, J. et al., “Biologic Markers as Predictors of Clinical Outcome from Systemic Therapy for Primary Operable Breast Cancer,”Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 17:(10) 3058-3063 (1999).
Chen-Hsiang Yeang et al., “Molecular Classification of Multiple Tumor Types”, Bioinformatics, vol. 17, Suppl. 1, pp. S316-S322 (2001).
Cox, G. et al., “Bcl-2 is an Independent Prognostic Factor and Adds to a Biological Model for Predicting Outcome in Operable Non-Small Cell Lung Cancer,”Lung Cancer, vol. 34:(3) 417-426 (2001).
Dijkema, I.M. et al., “Influence of p53 and bcl-2 on Proliferative Activity and Treatment Outcome in head and Neck Cancer Patients,”Oral Oncology, Elsevier Science, vol. 36:(1) 54-60 (2000).
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, pp. 531-537 (1999).
Guerin, M. et al., “Structure and Expression of C-ERBB-2 and EGF Receptor Genes in Inflammatory and Non-Inflammatory Breast Cancer: Prognostic Significance,”International Journal of Cancer, vol. 43 201-208 (1989).
Joensuu, H. et al., “Bcl-2 Protein Expresion and Long-Term Survival in Breast Cancer,”American Journal of Pathology, vol. 145:(5) 1191-1198 (1994).
Kymionis, G.D., et al., “Can Expression of Apoptosis Genes, bcl-2 and Bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?”The Journal of Surgical Research, vol. 99:(2) 161-168 (2001).
Locker, A.P., et al., “Ki67 Immunoreactivity in Breast Carcinoma: Relationships to prognostic Variable and Short time Survival,”European Journal of Surgical Oncology, vol. 18:(3) 224-229 (1992).
Martin et al., “Linking Gene Expression Patterns

Affiliated with

Also associated with

Rating

Gene expression profiling in biopsied tumor tissues does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene expression profiling in biopsied tumor tissues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression profiling in biopsied tumor tissues will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4230612